EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adrenal-derived factors drive progression of sclerotic prostate cancer in bone

Malin Hagberg Thulin iD, Lei Li, Sanna Abrahamsson, Andreas Landin, Karin Horkeby iD, Jianyao Wu, Marie K Lagerquist, Claes Ohlsson, Matti Poutanen iD

Endocrine-Related Cancer · 01.06.2026 · 33 (6)

DOI: 10.1530/erc-25-0309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, online erschienen am 18.05.2026. Verfasst von Malin Hagberg Thulin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Researc…. Hauptthemen laut MEDLINE: Bone Neoplasms, Prostatic Neoplasms, Castration-Resistant, Adrenal Glands. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone metastasis is a leading cause of death in prostate cancer (PC) patients. Although androgen deprivation therapy (ADT) combined with novel androgen-targeted agents constitutes the cornerstone of systemic treatment, its efficacy is limited. We investigated the adrenal contribution to promoting progression of castration-resistant PC (CRPC) within bone using a preclinical intratibial xenograft model (VCaP, 22Rv1, and LNCaP cells). Mice underwent orchiectomy (ORX) to mimic ADT, with or without adrenalectomy (ORX + ADX) to eliminate adrenal contribution. A significant increase in bone mineral density (BMD) was observed in tumor-grafted tibiae in ORX-treated mice compared with controls (P < 0.001), indicating a strong tumor-induced sclerotic response. In contrast, ORX + ADX reduced tumor take rate by approximately 50% and decreased tumor-induced BMD by over 80% (P < 0.001). Transcriptomic analysis revealed that ADX downregulated tumor-induced transcripts in bone by over 90%, including osteogenic (Lox, Sparcl1, Bmp2, Postn, and Col1a1) and pro-angiogenic (Bmper, Pecam-1, and Esam) signatures. In addition, BMP, PI3K/Akt, and ERK1/2 signaling pathways were associated with the tumor-induced bone response. Both high serum progesterone and intratumoral levels of dihydrotestosterone (DHT) were associated with the sclerotic bone phenotype. ADX markedly reduced intratumoral DHT and downregulated glycolytic genes (HK2, PFK2, and LDHA) and secretory proteins expressed by the tumor, including stanniocalcin 2, potentially mediating paracrine effects in the sclerotic bone response. Altogether, these findings highlight the critical role of adrenal-dependent androgen synthesis, particularly via progesterone, in driving the sclerotic CRPC in bone. Our findings suggest that a comprehensive blockade of adrenal contribution is essential to prevent the sclerotic bone response associated with CRPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsProstatic Neoplasms, Castration-ResistantAdrenal GlandsMaleAnimalsHumansMiceDisease ProgressionSclerosisCell Line, TumorBone DensityAdrenalectomy

Stichwörter der Autor:innen

adrenal glandsangiogenesisbone metastasiscastration-resistant prostate cancerdihydrotestosteroneosteogenesissclerotic bonesex hormones

Autor:innen und Institutionen

  • Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research at The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sw…
  • Bioinformatics and Data Centre, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine and Turku Center for Disease Modeling, University of Turku, Turku, Finland.
  • FICAN West Cancer Center, University of Turku and Turku University Hospital, Turku, Finland.

ORCID-Profile: Malin Hagberg Thulin, Karin Horkeby, Matti Poutanen

Zitieren

APA

Hagberg Thulin, M., Li, L., Abrahamsson, S., Landin, A., Horkeby, K., Wu, J., Lagerquist, M. K., Ohlsson, C., & Poutanen, M. (2026). Adrenal-derived factors drive progression of sclerotic prostate cancer in bone. Endocrine-Related Cancer, 33(6). https://doi.org/10.1530/erc-25-0309

Vancouver

Hagberg Thulin M, Li L, Abrahamsson S, Landin A, Horkeby K, Wu J, et al. Adrenal-derived factors drive progression of sclerotic prostate cancer in bone. Endocrine-Related Cancer. 2026;33(6). doi:10.1530/erc-25-0309

BibTeX
@article{HagbergThulin2026,
  author = {Hagberg Thulin, Malin and Li, Lei and Abrahamsson, Sanna and Landin, Andreas and Horkeby, Karin and Wu, Jianyao and Lagerquist, Marie K and Ohlsson, Claes and Poutanen, Matti},
  title = {Adrenal-derived factors drive progression of sclerotic prostate cancer in bone},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  volume = {33},
  number = {6},
  doi = {10.1530/erc-25-0309}
}
Kostenlos starten →